Ovid Therapeutics Inc.
OVID- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636651
No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Ovid Therapeutics Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 88 | 1 | 80 | −7 |
| Shares | 36.3M | 71.7K | 33.4M | −2.79M (−7.7%) |
| Value | $145.7M | $288.0K | $130.5M | −$14.9M (−10.2%) |
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Ovid Therapeutics Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Globeflex Capital L P | 1,009,125 | $3.95M | 0.71% |
| Millennium Management LLC | 765,650 | $2.99M | 0.00% |
| Two Sigma Investments, LP | 288,780 | $1.13M | 0.00% |
| Ergoteles LLC | 197,389 | $772.0K | 0.02% |
| HRT Financial LP | 131,515 | $514.0K | 0.00% |
| SEI Investments Co | 80,697 | $316.0K | 0.00% |
| Tibra Equities Europe Ltd | 78,700 | $308.0K | 0.10% |
| ExodusPoint Capital Management, LP | 53,935 | $211.0K | 0.00% |
| XTX Topco Ltd | 50,569 | $198.0K | 0.07% |
| Squarepoint Ops LLC | 37,797 | $148.0K | 0.00% |
| Diversified Trust Co | 35,063 | $137.0K | 0.00% |
| LMR Partners LLP | 26,199 | $102.0K | 0.00% |
| Parametric Portfolio Associates LLC | 22,864 | $89.0K | 0.00% |
| Jump Financial, LLC | 16,200 | $63.0K | 0.01% |
| Lazard Asset Management LLC | 14,156 | $55.0K | 0.00% |
| Campbell & CO Investment Adviser LLC | 13,700 | $54.0K | 0.02% |
| Engineers Gate Manager LP | 12,549 | $49.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 12,375 | $48.0K | 0.01% |
| Federated Hermes, Inc. | 250 | $1.00K | 0.00% |
| Beck Bode, LLC | 350 | $1.00K | 0.00% |
| Ellevest, Inc. | 53 | $0 | 0.00% |
Sold out (28)
Institutions that held Ovid Therapeutics Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
Not filed for Q2 2021 yet (1)
Institutions that held Ovid Therapeutics Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Fairpointe Capital LLC | 71,700 | $288.0K |